Ravenquest informiert über den Erhalt der Anbaulizenz und Erweiterung der Produktionskapazität

10.04.2019 ================================== Kommentar Cannabis-Redaktion: Mit dem Erhalt der Lizenz für die Edmonton facility kann die Produktion um 275% auf 11.000 kg gesteigert werden. Dies ist einen Meilenstein in der Expansionsstrategie der Gesellschaft.   ==================================   Ravenquest provides update on recent license and production capacity expansion April 10, 2019 April 10, 2019 – Vancouver, British Columbia

Read more

Canopy Growth und DNA Genetics verbreitern ihre Geschäftsbeziehung

19.03.2019 SMITHS FALLS, ON and LOS ANGELES, CA – Canopy Growth Corporation (“Canopy”) (TSX:WEED, NYSE: CGC) (“Canopy Growth” or the “Company”), a world-leading, diversified cannabis company and OG DNA Genetics (“DNA”), a globally recognized cannabis brand, are pleased to announce today they have signed an agreement to extend and expand upon their previously announced partnership through

Read more

Tilray, Inc. gibt Finanzergebnisse für das Gesamtjahr 2018 bekannt

18. März 2019 Revenue Rises 110.0% to $43.1 (C$56.4) Million in 2018 Strategic Partnerships and Acquisitions Position Tilray to Accelerate Global Sales Growth and Drive Long-Term Shareholder Value NANAIMO, British Columbia–(BUSINESS WIRE)–Mar. 18, 2019– Tilray, Inc., (“Tilray” or the “Company”) (Nasdaq: TLRY) a global leader in cannabis research, cultivation, production and distribution, today reported financial results for the fourth

Read more

Aurora Cannabis: Derivative Produkte mit hoher Marge beschleunigen das europäische Umsatzwachstum

11. März 2019   High-Margin Derivative Products Accelerating European Revenue Growth TSX | NYSE: ACB   EDMONTON, March 11, 2019 /CNW/ – Aurora Cannabis Inc. (the „Company“ or „Aurora“) (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) today announced that it has commenced sales of cannabis oils to German pharmacies following receipt of all necessary approvals

Read more

Cronos Group Inc. schließt strategisches Wachstumsinvestment in Höhe von 2,4 Milliarden US-Dollar seitens Altria Group Inc. ab

8. März 2019 Cronos Group Inc. Closes C$2.4 Billion Strategic Growth Investment from Altria Group, Inc.   Four New Directors Join Cronos Group Board Jerry Barbato Appointed Chief Financial Officer of Cronos Group; William Hilson Appointed Chief Commercial Officer TORONTO, March 08, 2019 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced

Read more

GW Pharmaceuticals plc gibt Finanzergebnisse und operativen Fortschritt für das am 31. Dezember 2018 endende Quartal bekannt

26.02.2019 GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Quarter Ended December 31, 2018 LONDON and CARLSBAD, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the development and commercialization of cannabinoid prescription medicines, announces financial results for the

Read more

Aurora Cannabis expandiert nach Portugal und stärkt die Marktführerschaft in Europa

26. Februar 2019 Aurora Cannabis Expands into Portugal, Enhancing European Market Leadership New Production Facility to Expand Supply to European Medical Cannabis Systems, Increasing Aurora’s International Footprint to 24 Countries   EDMONTON, Feb. 26, 2019 /CNW/ – Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) today announced that it has agreed to terms to acquire

Read more

Canopy Growth Corporation gibt Finanzergebnisse für das dritte Quartal des Geschäftsjahres 2019 bekannt: Bruttoumsatz von 98 Mio. USD; Der Nettoumsatz erreicht einen Rekordwert von 83 Millionen US-Dollar

14.02.2019 Canopy Growth Corporation Reports Third Quarter Fiscal 2019 Financial Results: Gross Sales of $98M; Net Revenue hits record $83M • Cannabis shipments totaled 10,102 kilograms and kilogram equivalents. • Net income of $74.9 million, including changes in fair values of financial liabilities included in Other Income. • Closed the previously announced $5 billion investment

Read more

Aurora Cannabis gibt Finanzergebnisse für das zweite Quartal des Geschäftsjahres 2019 bekannt

11. Februar 2019   EDMONTON, Feb. 11, 2019 /CNW/ – Aurora Cannabis Inc. (the „Company“ or „Aurora„) (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM), announced today its financial and operational results for the second quarter ended December 31st, 2018. Q2 2019 and Subsequent Highlights Net revenue of $54.2 million, up 83% sequentially, and up 363% compared to the same

Read more